The FDA’s review of Regenxbio’s gene therapy for Hunter syndrome intensifies focus on biomarker validation in accelerated approvals, balancing innovation…
25% vaccination uptake rise among NHS App users shows preventive healthcare shift
The NHS App is evolving into a central platform for preventive healthcare in the UK, with clinical evidence indicating a…
What FDA’s CRISPR approvals mean for rare disease economics
The FDA’s 2023 approval of CRISPR therapies for sickle cell disease and beta-thalassemia highlights clinical benefits like reduced crises and…
AI scheduling tools reshape hospital economics amid nursing shortages
Hospitals using AI-powered scheduling systems report 22-28% overtime cost reductions and 15-18% nurse retention improvements. New ROI models show payback…
AI and automation reshape echocardiography workflows while addressing ergonomic challenges
Recent advancements in AI-guided echocardiography are reducing scan times by 30-50% while minimizing sonographer musculoskeletal strain through automated plane detection…
AI-Guided Ultrasound Systems Demonstrate 90-98% Diagnostic Accuracy While Cutting Training Costs
Recent FDA clearances and clinical validations show AI-guided ultrasound enables non-specialists to detect deep vein thrombosis with near-expert accuracy, potentially…
AI Advancements Transform Cardiac CT Imaging and Diagnostic Accuracy
Recent FDA clearances and clinical studies demonstrate AI’s growing role in enhancing cardiac CT capabilities, from improved plaque analysis to…
Even modest medication adherence can yield significant financial benefits for health systems
Improving medication adherence, even slightly, can lead to substantial reductions in hospitalizations and better patient outcomes, particularly for chronic conditions…